Aspira Pathlab & Diagnostics Limited is an India-based company that is engaged in the business of running, owning, managing and administering diagnostics centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1 and COVID-19 Detection Profile 2.
Metrics to compare | ASPR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASPRPeersSector | |
---|---|---|---|---|
P/E Ratio | −24.8x | 18.5x | −0.6x | |
PEG Ratio | 0.08 | 0.32 | 0.00 | |
Price/Book | 4.7x | 3.0x | 2.6x | |
Price / LTM Sales | 3.1x | 3.8x | 3.2x | |
Upside (Analyst Target) | - | −0.6% | 48.4% | |
Fair Value Upside | Unlock | 2.0% | 6.8% | Unlock |